[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-HCJ7rgGjlOp1MkUGwMJFjeMZPBOOUFHN47HJ38h9EA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"Nova Southeastern University",[4],78,false,22,2,8296,5,73,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Depression",4,{"name":18,"count":19},"Low Back Pain",3,{"name":21,"count":19},"Amyotrophic Lateral Sclerosis (ALS)",{"name":23,"count":9},"HIV",{"name":25,"count":9},"Gulf War Illness",{"name":27,"count":9},"Visual Function",{"name":29,"count":9},"HIV Infections",{"name":31,"count":9},"Heart Failure",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT04254627","TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset","2025-09","Etanercept",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06211062","The Use of Directed Probiotics in ME\u002FCFS: Myalgic Encephalomyelitis\u002FChronic Fatigue Syndrome","2026-02-24","Floradapt Intensive GI",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT04987775","GWICTIC: NAC Mechanistic Study in Gulf War Veterans","2026-04","N-Acetyl Cysteine",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT05442034","Rh-PDGF vs EMD for Treatment of Intra-bony Defects","2027-06-30","growth factors to help in regeneration",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,85,107,129,147,168],{"intervention":52,"totalTrials":62,"cells":63},1,{"EARLY_PHASE1":64,"PHASE1":67,"PHASE2":69,"PHASE3":79,"PHASE4":81,"NA":83},{"trials":65,"activeCount":66},[],0,{"trials":68,"activeCount":66},[],{"trials":70,"activeCount":62,"soonestReadout":51},[71],{"nctId":49,"briefTitle":50,"status":72,"phases":73,"primaryCompletion":51,"completion":51,"start":74,"enrollment":75,"conditions":76,"interventions":78},"RECRUITING",[55,56],"2023-01-01",36,[77],"Intrabony Periodontal Defect",[52],{"trials":80,"activeCount":66},[],{"trials":82,"activeCount":66},[],{"trials":84,"activeCount":66},[],{"intervention":42,"totalTrials":62,"cells":86},{"EARLY_PHASE1":87,"PHASE1":89,"PHASE2":91,"PHASE3":101,"PHASE4":103,"NA":105},{"trials":88,"activeCount":66},[],{"trials":90,"activeCount":66},[],{"trials":92,"activeCount":62,"soonestReadout":41},[93],{"nctId":39,"briefTitle":40,"status":72,"phases":94,"primaryCompletion":41,"completion":41,"start":95,"enrollment":96,"conditions":97,"interventions":100},[56],"2022-12-20",100,[98,99],"ME\u002FCFS","IBS - Irritable Bowel Syndrome",[42],{"trials":102,"activeCount":66},[],{"trials":104,"activeCount":66},[],{"trials":106,"activeCount":66},[],{"intervention":37,"totalTrials":62,"cells":108},{"EARLY_PHASE1":109,"PHASE1":111,"PHASE2":121,"PHASE3":123,"PHASE4":125,"NA":127},{"trials":110,"activeCount":66},[],{"trials":112,"activeCount":62,"soonestReadout":36},[113],{"nctId":34,"briefTitle":35,"status":114,"phases":115,"primaryCompletion":36,"completion":36,"start":116,"enrollment":117,"conditions":118,"interventions":119},"ACTIVE_NOT_RECRUITING",[55],"2021-09-24",20,[25],[37,120],"Mifepristone",{"trials":122,"activeCount":66},[],{"trials":124,"activeCount":66},[],{"trials":126,"activeCount":66},[],{"trials":128,"activeCount":66},[],{"intervention":120,"totalTrials":62,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":139,"PHASE3":141,"PHASE4":143,"NA":145},{"trials":132,"activeCount":66},[],{"trials":134,"activeCount":62,"soonestReadout":36},[135],{"nctId":34,"briefTitle":35,"status":114,"phases":136,"primaryCompletion":36,"completion":36,"start":116,"enrollment":117,"conditions":137,"interventions":138},[55],[25],[37,120],{"trials":140,"activeCount":66},[],{"trials":142,"activeCount":66},[],{"trials":144,"activeCount":66},[],{"trials":146,"activeCount":66},[],{"intervention":47,"totalTrials":62,"cells":148},{"EARLY_PHASE1":149,"PHASE1":158,"PHASE2":160,"PHASE3":162,"PHASE4":164,"NA":166},{"trials":150,"activeCount":62,"soonestReadout":46},[151],{"nctId":44,"briefTitle":45,"status":72,"phases":152,"primaryCompletion":46,"completion":46,"start":153,"enrollment":154,"conditions":155,"interventions":157},[54],"2023-11-30",170,[156],"Gulf War Syndrome",[47],{"trials":159,"activeCount":66},[],{"trials":161,"activeCount":66},[],{"trials":163,"activeCount":66},[],{"trials":165,"activeCount":66},[],{"trials":167,"activeCount":66},[],{"intervention":169,"totalTrials":62,"cells":170},"Oxygen 100 % Gas for Inhalation",{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":187,"PHASE3":189,"PHASE4":191,"NA":193},{"trials":172,"activeCount":66},[],{"trials":174,"activeCount":66},[175],{"nctId":176,"briefTitle":177,"status":178,"phases":179,"primaryCompletion":180,"completion":180,"start":181,"enrollment":182,"conditions":183,"interventions":186},"NCT06665633","Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy","COMPLETED",[55],"2025-07-01","2021-09-07",40,[184,185,15],"Mild Traumatic Brain Injury","Hyperbaric Oxygen Therapy",[169],{"trials":188,"activeCount":66},[],{"trials":190,"activeCount":66},[],{"trials":192,"activeCount":66},[],{"trials":194,"activeCount":66},[]]